Osteoarthritis D010003

Diseases [C] » Musculoskeletal Diseases [C05] » Joint Diseases » Arthritis » Osteoarthritis

Diseases [C] » Musculoskeletal Diseases [C05] » Rheumatic Diseases » Osteoarthritis

Description

A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.   MeSH

Subtype Terms (3)

Osteoarthritis, Hip
60 drugs (37 approved, 23 experimental)

Osteoarthritis, Knee
319 drugs (105 approved, 214 experimental)

Osteoarthritis, Spine
3 drugs (2 approved, 1 experimental)


Phase 4 Indicated Drugs (92)

Key: D010003 (85) Subtype (7)

Phase 3 Indicated Drugs (98)

Key: D010003 (92) Subtype (6)

Phase 2 Indicated Drugs (111)

Key: D010003 (107) Subtype (4)


Organization Involved with Phase 4 Indications (159)

Key: D010003 (142) Subtype (17)

Organization Involved with Phase 3 Indications (199)

Key: D010003 (194) Subtype (5)

Organization Involved with Phase 2 Indications (157)

Key: D010003 (148) Subtype (9)

Organization Involved with Other Experimental Indications (106)

Key: D010003 (91) Subtype (15)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.